Related Experiment Videos
Women and coronary heart disease
1University of Tampa, Tampa, Fla., USA.
Insights
Coronary heart disease (CHD) affects both sexes, but women often present with atypical symptoms. Recognizing these gender differences is crucial for effective CHD assessment, diagnosis, and management in women.
Area of Science:
- Cardiology
- Gender-specific Medicine
- Public Health
Background:
- Coronary heart disease (CHD) is a leading cause of death in the U.S. for both men and women.
- While incidence is lower in women during midlife, the gap narrows with age, leading to equal absolute numbers of CHD deaths due to longer female lifespan.
- Effective CHD diagnosis in women necessitates understanding gender-specific presentation and pathogenesis.
Purpose of the Study:
- To highlight the critical gender differences in Coronary Heart Disease (CHD).
- To examine the unique assessment, diagnosis, and clinical management strategies for CHD in women.
- To improve the recognition of atypical CHD symptoms in women.
Main Methods:
- Review of current literature on gender differences in CHD.
- Analysis of epidemiological data regarding CHD incidence and mortality in men versus women.
- Examination of clinical guidelines and diagnostic criteria for CHD, emphasizing sex-specific considerations.
Main Results:
- Women often exhibit atypical symptoms of CHD compared to men.
- Women are less likely to receive adequate primary prevention for CHD.
- Despite lower incidence rates in midlife, CHD mortality in women is substantial due to longer life expectancy.
Conclusions:
- Understanding gender disparities in CHD presentation and risk factors is vital for accurate diagnosis.
- Tailored approaches to primary prevention and clinical management are essential for improving cardiovascular health outcomes in women.
- Further research into sex-specific pathways of CHD pathogenesis is warranted.
Abstract:
Coronary heart disease (CHD) is the leading cause of death in men and women in the United States. The incidence of CHD during midlife is lower in women than men, but the gap narrows with each decade. Because women have a longer life span than men, the absolute numbers of CHD deaths are roughly equal. Effective diagnosis of CHD in women requires the recognition of gender differences in presentation and pathogenesis. Women present with atypical symptoms and are less likely to have adequate primary prevention. This article discusses the differences between men and women in CHD and examines the assessment, diagnosis, and clinical management of CHD in women.